FHIRsmith: FHIR Resources

FHIR IG analytics

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | pt | se | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds

271,123 resources (JSON | CSV)

Type:
Text: Package: Only Show Used

By Version

R2: 117
R2B: 0
R3: 21,787
R4: 158,482
R4B: 43,719
R5: 32,546
R6: 2,265

By Authority

none: 189,698
hl7: 74,867
ihe: 1,324
national: 3,888
who: 1,346

By Realm

none: 183,643
au: 736
be: 606
br: 400
ca: 1,464
ch: 1,775
cl: 564
cr: 117
cz: 861
de: 2,090
dk: 1,497
ee: 260
eu: 967
fi: 87
fr: 3,341
il: 328
in: 163
it: 116
jp: 174
kr: 30
nl: 2,247
no: 125
nz: 240
pl: 258
pt: 50
se: 161
stt: 116
tw: 1,414
uk: 6
us: 23,064
uv: 44,079
vn: 108
other: 6

Start Prev Rows 221800 - 222000 Next

Package	Version	Identity	Name/Title	Status	Date	Realm	Auth	Usage #
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.643.json	Antiplatelets	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.644.json	Anticoagulants	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.645.json	Statin Medications	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.646.json	Anxiety Disorders (ICD10 and SNOMED)	active	2023-10	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.648.json	Depression Diagnosis (ICD10 and SNOMED)	active	2023-10	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.649.json	Psychosis (ICD10 and SNOMED)	active	2023-10	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.650.json	Cluster Headache (SNOMED)	active	2023-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.651.json	Galcanezumab (RxNorm)	active	2023-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.652.json	Lithium (RxNorm)	active	2023-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.653.json	Verapamil	active	2023-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.654.json	Long term preventive medications for cluster headache	active	2023-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.655.json	Short term preventive medication for cluster headache	active	2023-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.656.json	Zolmitriptan	active	2023-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.657.json	Sumatriptan	active	2023-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.658.json	Dihydroergotamine	active	2023-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.659.json	Acute cluster headache medication	active	2023-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.660.json	Acute cluster headache treatment	active	2023-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.661.json	Short term preventive treatment for cluster headache	active	2023-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.662.json	Long term preventive treatment for cluster headache	active	2023-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.663.json	Migraine diagnosis (ICD)	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1034.664.json	Prescribable NSAIDs and Acute Migraine Attack Medication	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.103.json	Abnormal Presentation	active	2023-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.105.json	Abnormal Presentation	active	2021-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.130.json	Respiratory Rate	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.15.json	Intravenous Thrombolytic tPA Therapy	active	2021-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.16.json	Intraarterial Thrombolytic tPA Therapy	active	2021-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.163.json	Systolic Blood Pressure	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.171.json	Abnormal Presentation	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.173.json	Delivery of Singleton	active	2021-06	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.21.json	Intravenous or Intraarterial Thrombolytic tPA Therapy	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.26.json	Estimated Gestational Age at Delivery	active	2021-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.27.json	Cornual Ectopic Pregnancy	active	2021-06	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.38.json	General Or Neuraxial Anesthesia	active	2021-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.39.json	Low Dose Unfractionated Heparin for VTE Prophylaxis	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.41.json	Glycoprotein IIb IIIa Inhibitors	active	2023-01	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.55.json	Oxytocin	active	2021-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.56.json	Dinoprostone	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.58.json	Delivery Procedures	active	2021-06	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.59.json	Delivery Procedures	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.67.json	PCI	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.68.json	Endotracheal Intubation	active	2018-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.69.json	Endotracheal Intubation	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.98.json	Delivery of Singleton	active	2021-06	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1045.99.json	Delivery of Singleton	active	2021-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.225.json	Opioid Medication Assisted Treatment (MAT) SNOMED	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.241.json	Schedule II, III and IV Opioid Medications	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.242.json	Opioid Use Disorder	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.243.json	Opioid Use Disorder	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.265.json	Inpatient, Emergency, and Observation Locations	active	2022-07	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.269.json	Medications for Opioid Use Disorder (MOUD)	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.274.json	NHSN Inpatient Encounter Class Codes	active	2024-04	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.277.json	Emergency Department Location	active	2024-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.278.json	Emergency Department Treatment Location	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.283.json	Emergency Department Location	active	2024-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.284.json	Emergency Department Location	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.285.json	Mental Health Diagnosis without Substance Use Disorders	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.286.json	Decision to Transfer	active	2024-07	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1046.35.json	Healthcare Agent or Proxy Choices	active	2022-10	us	hl7	4
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.10.json	Breastfeeding	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.100.json	Familial Hypercholesterolemia	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.102.json	Rhabdomyolysis	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.107.json	Low Intensity Statin Therapy	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.12.json	Liver Disease	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.13.json	Rhabdomyolysis	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.19.json	Atherosclerosis and Peripheral Arterial Disease	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.20.json	Atherosclerosis and Peripheral Arterial Disease	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.21.json	Atherosclerosis and Peripheral Arterial Disease	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.22.json	Liver Disease ICD9	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.37.json	Stable and Unstable Angina	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.39.json	Cerebrovascular Disease Stroke or TIA	active	2023-02	us	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.41.json	Ischemic Heart Disease or Related Diagnoses	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.42.json	Liver Disease	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.43.json	Liver Disease	active	2021-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.44.json	Cerebrovascular Disease Stroke or TIA	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.46.json	Ischemic Heart Disease or Related Diagnoses	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.47.json	Stable and Unstable Angina	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.501.json	Overweight or Obese	active	2025-01	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.502.json	Overweight or Obese	active	2018-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.512.json	Elevated Blood Pressure Reading	active	2019-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.513.json	Elevated Blood Pressure Reading	active	2020-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.514.json	Finding of Elevated Blood Pressure or Hypertension	active	2019-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.515.json	Bariatric Procedures	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.517.json	Age related macular degeneration intermediate dry	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.518.json	Ophthalmologist visit	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.519.json	Posterior vitreous detachment (PVD)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.521.json	Ophthalmoscopic exam	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.523.json	Opthalmoscopic exams with Scleral Depression	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.525.json	Referral (ophthalmology)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.526.json	Retina Ultrasound	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.527.json	Retina visualization inadequate	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.528.json	Refusal or Noncompliance with treatment	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.529.json	Vitreous hemorrhage	active	2024-06	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.530.json	Vitreous hemorrhage	active	2024-06	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.536.json	Macula examination	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.539.json	Fluorescein angiography	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.541.json	Optical coherence tomography (OCT)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.542.json	Intravitreal injection	active	2024-06	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.543.json	Bevacizumab injection	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.544.json	Ranibizumab injection	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.545.json	Aflibercept injection	active	2024-06	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.552.json	Uveitis	active	2024-06	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.553.json	Uveitis	active	2024-06	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.554.json	Post Cataract Surgery Cystoid Macular Edema AND Idiopathic Macular Edema	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.555.json	Macular edema	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.556.json	Corticosteroids for Injection	active	2024-06	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.557.json	Corticosteroids for Injection	active	2024-06	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.560.json	Tonometry	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.561.json	Intraocular pressure	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.571.json	Retinal Vein Occlusion Related Macular Edema	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.576.json	Vitreous hemorrhage	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.580.json	Intravitreal and Periocular Injections	active	2020-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.581.json	Intravitreal and Periocular Injections	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.582.json	Corticosteroids for Injection	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.583.json	Endophthalmitis in the Right Eye	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.584.json	Endophthalmitis in the Left Eye	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.585.json	Panophthalmitis in the Right Eye	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.586.json	Panophthalmitis in the Left Eye	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.587.json	Lost to follow up	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.588.json	Uveitis	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.610.json	Scleral depressed exam	active	2020-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.611.json	3 Mirror Goldmann exam	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.612.json	Scleral depressed exam	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.615.json	Physical Disability	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.616.json	Financial difficulty	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.617.json	Vitreous exam findings	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.619.json	Scleral depressed exam	active	2020-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.629.json	Post operative follow up	active	2020-07	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.67.json	Breastfeeding	active	2017-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.69.json	Stable and Unstable Angina	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.70.json	Ischemic Heart Disease or Related Diagnoses	active	2021-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.71.json	Cerebrovascular Disease Stroke or TIA	active	2023-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.73.json	Breastfeeding	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.85.json	Familial Hypercholesterolemia	active	2023-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.89.json	Rhabdomyolysis	active	2017-05	us	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.9.json	Outpatient Encounters for Preventive Care	active	2019-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.91.json	Familial Hypercholesterolemia	active	2021-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.93.json	Hypercholesterolemia ICD 9	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.97.json	High Intensity Statin Therapy	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1047.98.json	Moderate Intensity Statin Therapy	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1056.50.json	HIV Lab Tests	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1056.51.json	Indicators of Human Immunodeficiency Virus (HIV)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1056.52.json	Indicators of Human Immunodeficiency Virus (HIV)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1056.53.json	Indicators of Human Immunodeficiency Virus (HIV)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1056.71.json	Human Immunodeficiency Virus (HIV) Viral Load	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.10.json	ARBs (Angiotensin Receptor Blockers)	active	2024-12	us	hl7	3
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1000.json	OIA_V2_GLP1s_RxNorms	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1001.json	OIA_V2_PCSK9s_RxNorms	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1002.json	OIA_RFs_Secondary_Prevention_ICD10	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1003.json	OIA_RFs_Secondary_Prevention_SNOMED	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1004.json	OIA_RFs_Secondary_Prevention_CPT	active	2025-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1005.json	OIA_RFs_Secondary_Prevention_ICD_SM_CPT	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1006.json	OIA_Asthma_COPD_Combo_Meds	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1007.json	OIA_Asthma_COPD_Combo_Meds_SABA_SAMA	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1008.json	OIA_Asthma_COPD_Combo_Meds_LABA_LAMA_ICS	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1009.json	PAE_Patient_Conditions	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1012.json	PAE Conditions Short	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1016.json	OIA_TEST_VS	active	2025-03	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1017.json	Triptan Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1018.json	NSAID Allergy NDFRT	active	2025-04	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1019.json	Statin Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1021.json	Penicillin Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1022.json	Macrolide Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1023.json	Quinolone Allergy NDFRT	active	2025-04	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1025.json	Beta blocker Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1026.json	ACE inhibitor Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1027.json	ARB Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1028.json	Sulfonylurea Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1030.json	DPP4i Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1031.json	GLP1RA Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1032.json	Beta blocker allergy intolerance	active	2025-04	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1033.json	SGLT2i Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1034.json	MRA Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1036.json	Meglitinide Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1037.json	Alpha glucosidase inhibitor Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1038.json	TZD Allergy NDFRT	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1041.json	Hemoglobin	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1042.json	Hematocrit	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1043.json	Anemia for Erythropoesis Simulating Agents I10	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1044.json	Anemia for Erythropoesis Simulating Agents SCT	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1045.json	Anemia for Erythropoesis Simulating Agents	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1046.json	AZT Meds	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1047.json	Ferritin	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1048.json	Knee pain I10	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1049.json	Knee pain SCT	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.105.json	conditions_heartfailure	active	2023-07	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1050.json	Knee pain	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1051.json	Knee decreased ROM SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1052.json	Knee effusion I10	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1054.json	Knee effusion	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1055.json	Knee crepitus SCT	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1056.json	OIA_Antiemetics	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1057.json	OIA_PDE5is	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1058.json	OIA_Vitamins	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1059.json	OIA_Plavix	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1061.json	OIA_Oral_Contraceptives	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1063.json	OIA_Topical_Steroids	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1064.json	OIA_Cough_Cold_Meds	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1065.json	Antiperspirant aluminum salts	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1066.json	Antiperspirant anticholinergics	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1078.1067.json	Antieplieptic medications	active	2025-05	us	hl7